A Study to Assess the Safety and Pharmacokinetics of HBI-002, an Oral Carbon Monoxide Therapeutic, in Healthy Volunteers
Clinical trial NCT03926819 · COMPLETED
Trial details
- NCT number
- NCT03926819
- Sponsor
- Hillhurst Biopharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-25
- Primary completion
- 2023-04-26
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.